Mambrini, Andrea <br/><br/>
Systemic gemcitabine and capecitabine plus intra-arterial epirubicin and cisplatin as second-line chemotherapy in gemcitabine-failure pancreatic cancer.  [electronic resource] 

 -  Pancreas  Aug 2011 
 - 983-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter 
<br/><br/><label>ISSN: </label>1536-4828 
<br/><br/><label>Standard No.: </label>10.1097/MPA.0b013e3182164002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Capecitabine<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Epirubicin--administration & dosage<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Infusions, Intra-Arterial<br/>Pancreatic Neoplasms--drug therapy<br/>Prospective Studies<br/>Survival Analysis<br/>Treatment Failure<br/>Gemcitabine